Proton pump inhibitors as also inhibitors of atrial fibrillation

European Journal of Pharmacology

Volumn 718, Issue 1-3, 2013, Pages 435-440

  Lin, Kun ^a   Chen, Xinpei ^a   Zhang, Li ^b   Wang, Yutang ^a   Shan, Zhaoliang ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b JIAMUSI UNIVERSITY   (China)

Author keywords

Atrial fibrillation; Gastroesophageal reflux disease; Proton pump inhibitors

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ASCORBIC ACID; C REACTIVE PROTEIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ESOMEPRAZOLE; GLUCOCORTICOID; HEME OXYGENASE 1; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERLEUKIN 8; LANSOPRAZOLE; OMEPRAZOLE; PANTOPRAZOLE; POLYUNSATURATED FATTY ACID; PROTON PUMP INHIBITOR; SUPEROXIDE; TRANSCRIPTION FACTOR NRF2;

ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; DRUG POTENCY; GASTROESOPHAGEAL REFLUX; HEART ATRIUM FIBRILLATION; HISTOPATHOLOGY; HUMAN; INFLAMMATION; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; STOMACH ACID SECRETION; UNSPECIFIED SIDE EFFECT;

ATRIAL FIBRILLATION; GASTROESOPHAGEAL REFLUX DISEASE; PROTON PUMP INHIBITORS;

ANIMALS; ATRIAL FIBRILLATION; HUMANS; PROTON PUMP INHIBITORS; PROTON PUMPS;

EID: 84887041935     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2013.07.043     Document Type: Review

References (69)

1. R.J. Aviles, D.O. Martin, and C. Apperson-Hansen Inflammation as a risk factor for atrial fibrillation Circulation 108 24 2003 3006 3010 (Pubitemid 37553570)
2. M. Baggiolini, P. Loetscher, and B. Moster Interleukin-8 and the chemokine family International Journal of Immunopharmacology 17 1995 103 108
3. J.C. Becker, W. Domschke, and T. Pohle Current approaches to prevent NSAID-induced gastropathy-COX selectivity and beyond British Journal of Clinical Pharmacology 58 6 2004 587 600 (Pubitemid 39665146)
4. J.C. Becker, N. Grosser, and C. Waltke Beyond gastric acid reduction:proton pump inhibitors induce heme oxygenase-1 in gastric and endothelial cells Biochemical and Biophysical Research Communications 345 3 2006 1014 1021 (Pubitemid 43776514)
5. E.J. Benjamin, P.A. Wolf, and R.B. D′Aqostino Impact of atrial fibrillation on the risk of death: the Framingham Heart Study Circulation 98 10 1998 946 952 (Pubitemid 28446646)
6. K. Biswas, U. Bandyopadhyay, and I. Chattopadhyay A novel antioxidant and antiapoptotic role of omerprazole to block gastric ulcer through scavenging of hydroxyl radical Journal of Biological Chemistry 278 13 2003 10993 11001 (Pubitemid 36792647)
7. C. Blandizzi, G. Natale, and G. Gherardi Acid-independent gastroprotective effects of lansoprazole in experimental mucosal injury Digestive Diseases and Sciences 44 10 1999 2039 2050 (Pubitemid 29510815)
8. C. Blandizzi, M. Fornai, and R. Colucci Lansoprazole prevents experimental gastric injury induced by non-steoidal anti-inflammatory drugs through a reduction of mucosal oxidative damage World Journal of Gastroenterology 11 26 2005 4052 4060 (Pubitemid 41235603)
9. J. Budzyński, M. Kłopocka, and G. Pulkowski Gastroesophageal acid reflux as a causative factor of paroxysmal atrial fibrillation Kardiologia Polska 62 1 2005 52 54 (Pubitemid 40203869)
10. T.J. Bunch, D.L. Packer, and A. Jahanqir Long-term risk of atrial fibrillation with symptomatic gastroesophageal reflux disease and esophagitis American Journal of Cardiology 102 9 2008 1207 1211
11. C.A. Carnes, M.K. Chung, and T. Nakayama Ascorbate attenuates atrial pacing-induced peroxynitrite formation and electrical remodeling and decreases the incidence of postoperative atrial fibrillation Circulation Research 89 6 2001 E32 E38
12. Wan-Leong Chin-Chou Huang, and Jiing-Chyuan Luo Chan Gastroesophageal reflux disease and atrial fibrillation: a nationwide population-based study PLoS One 7 10 2012 e47575
13. P.J. De Jonge, P.D. Siersema, and S.G. Van Breda Proton pump inhibitor therapy in gastro-oesophageal reflux disease decreases the oesophageal immune response but does not reduce the formation of DNA adducts (Epub 2008 Mar 31) Alimentary Pharmacology and Therapeutics 28 1 2008 127 136 (Pubitemid 351782808)
14. H. Duygu, F. Ozerkan, and S. Sayqi Persistant atrial fibrillation associated with gastroesophageal reflux accompanied by hiatal hernia Anadolu Kardiyoloji Dergisi 8 2 2008 164 165 (Pubitemid 351586245)
15. M.D.M. Engelmann, and J.H. Svendsen Inflammation in the genesis and perpetuation of atrial fibrillation European Heart Journal 26 2005 2083 2092 (Pubitemid 41408600)
16. E.O. Farombi, and Y.J. Surh Heme oxygenase-1 as a potential therapeutic target for hepatoprotection Journal of Biochemistry and Molecular Biology 39 5 2006 479 491 (Pubitemid 44714527)
17. R.C. Fitzgeralf, B.A. Onwuegbusi, and M. Bajaj-Elliott Diversity in the oesophageal phenotypic response to gastro-oesophageal reflux: immunological determinants Gut 50 4 2002 451 459 (Pubitemid 34638860)
18. V. Fuster, L.E. Ryden, and D.S. Cannom ACC/AHA/ESC 2006 guedeines for the management of patients with atrial fibrillation-executive summary European Heart Journal 27 16 2006 1979 2030
19. L.B. Gerson, K. Friday, and G Triadafilopoulos Potential relationship between gastroesophageal reflux disease and atrial arrhthmias Journal of Clinical Gastroenterology 40 9 2006 828 832 (Pubitemid 44506928)
20. O. Handa, N. Yoshida, and N. Fujita Molecular mechanisms involved in anti-inflammatory effects of proton pump inhibitors Inflammation Research 55 11 2006 476 480
21. M. Harada, S. Shakado, and S. Sakisaka Bafilomycin A1, a specific inhibitor of V-type H+-ATPases, inhibits the acidification of endocytic structures and inhibits horseradish peroxidase uptake in isolated rat sinusoidal endothelial cells Liver 17 5 1997 244 250 (Pubitemid 27480429)
22. T. Hayakawa, Y. Fujiwara, and M. Hamaguchi Roles of cyclooxygenase 2 and microsomal prostaglandin E synthase 1 in rat acid reflux oesophagitis Gut 55 4 2006 450 456
23. U. Heinzow, and T. Schlegelberger Omeprazole in ulcerative colitis Lancet 343 1994 477
24. T. Hershcovici, and R. Fass Pharmacological management of GERD: where does it stand now? Trends in Pharmacological Sciences 32 4 2011 258 264
25. T. Hershcovici, and R. Fass Gastro-oesophageal reflux disease: beyond proton pump inhibitor therapy Drugs 71 18 2011 2381 2389
26. C.X. Huang, Y. Liu, and W.F. Xia Oxidative stress: a possible pathogenesis of atrial fibrillation Medical Hypotheses 72 4 2009 466 467
27. H. Ichikawa, N. Yoshida, and T. Takagi Lansoprazole ameliorates intestinal mucosal damage induced by ischemia-reperfusion in rats World Journal of Gastroenterology 10 19 2004 2814 2817 (Pubitemid 39302995)
28. H. Isomoto, A. Wang, and Y. Mizuta Elevated levels of chemokines in esophageal mucosa of patients with reflux esophagitis American Journal of Gastroenterology 98 3 2003 551 556 (Pubitemid 36348524)
29. H. Isomoto, Y. Nishi, and A. Wang Mucosal concentrations of proinflammatory cytokines and chemokines at gastric cardia: implication of Helicobacter pylori infection and gastroesophageal reflux American Journal of Gastroenterology 99 6 2004 1063 1068 (Pubitemid 38917809)
30. H. Isomoto, Y. Nishi, and Y. Kanazawa Immune and inflammatory responses in GERD and lansoprazole Journal of Clinical Biochemistry and Nutrition 41 2 2007 84 91 (Pubitemid 47529303)
31. T.T. Issac, H. Dokainish, and N.M. Lakkis Role of inflammation in initiation and perpetuation of atrial fibrillation: a systematic review of the published data Journal of the American College of Cardiology 50 21 2007 2021 2028 (Pubitemid 350087568)
32. Y. Kanazawa, H. Isomoto, and C.Y. Wen Impact of endoscopically minimal involvement on IL-8 mRNA expression in esophageal mucosa of patients with non-erosive reflux disease World Journal of Gastroenterology 9 12 2003 2801 2804 (Pubitemid 38054464)
33. R.R. Kedika, R.F. Souza, and S.J. Spechler Potential anti-inflammatory effects of proton pump inhibitors: a review and discussion of the clinical implications Digestive Diseases and Sciences 54 11 2009 (2312-7)
34. Y.J. Kim, J.S. Lee, and K.S. Hong Novel application of proto pump inhibitor for the prevention of colitis-induced colorectal carcinogenesis beyond acid suppression Cancer Prevention Research (Philadelphia, PA) 3 8 2010 963 974
35. T.R. Koch, A. Petro, and M. Darrabie Effect of the H, K-ATPase inhibitor, esomeprazole magnesium, on gut total anti-oxidant capacity in mice Journal of Nutritional Biochemistry 15 9 2004 522 526 (Pubitemid 39209394)
36. P. Korantzopoulos, T. Kolettis, and K. Siogas Atrial fibrillation and electrical remodeling: the potential role of inflammation and oxidative stress Medical Science Monitor 9 9 2003 RA225 RA229
37. M. Kuroda, N. Yoshida, and H. Ichikawa Lansoprazole, a proton pump inhibitor, reduces the severity of indomethacin-induced rat enteritis International Journal of Molecular Medicine 17 1 2006 89 93
38. C. Lafourcade, K. Sobo, and S. Kieffer-Jaquinod Regulation of the V-ATPase along the endocytic pathway occurs through reversible subunit association and membrane localization PLoS One 3 7 2008 e2758
39. P.H. Lin, S.H. Lee, and C.P. Su Oxidative damage to mitochondrial DNA in atrial muscle of patients with atrial fibrillation Free Radical Biology and Medicine 35 10 2003 1310 1318
40. W.H. Maisel, J.D. Rawn, and W.G. Stevenson Atrial fibrillation after cardic surgery Annals of Internal Medicine 135 2001 1061 1073
41. M.L. Marino, S. Fais, and M. Djavaheri-Mergny Proton pump inhibition induces autophagy as a survival mechanism following oxidative stress in human melanoma cells Cell Death and Disease 1 2010 e87 (Oct 21)
42. + ionophore Inflammation Research 56 2007 105 111 (Pubitemid 46570795)
43. M.F. McCarty Practical prevention of cardiac remodeling and atrial fibrillation with full-spectrum antioxidant therapy and ancillary strategies (141-7. Epub 2010 Jan 18) Medical Hypotheses 75 2 2010
44. N. Mukaida, A. Harada, and K. Matsushima Interleukin-8(IL-8) and monocyte chemotactic and activating factor (MCAF/MCP-1), chemokines essentially involved in in flammatory and immune reactions Cytokine and Growth Factor Reviews 9 1 1998 9 23 (Pubitemid 28280533)
45. H. Nakamura, G. Nakaji, and H. Shimazu Case of paroxysmal atrial fibrillation improved after the administration of proton pump inhibitor for associated reflux esophagitis Fukuoka Igaku Zasshi 98 6 2007 270 276
46. S. Negi, A.A. Sovari, and S.C. Dudley Jr. Atrial fibrillation: the emerging role of inflammation and oxidative stress Cardiovascular and Hematological Disorders: Drug Targets 10 4 2010 262 268
47. O. Pastoris, M. Verri, and F. Boschi Effects of esomeprazole on glutathione levels and mitochondrial oxidative phosphorylation in the gastric mucosa of rats treated with indomethacin Naunyn-Schmiedeberg′s Archives of Pharmacology 378 4 2008 421 429
48. +-exchange and gastric H+/K+ ATPse on cell volume, intracellular pH and migration of human polymorphonuclear leucocytes British Journal of Pharmacology 124 4 1998 627 638 (Pubitemid 28276798)
49. M. Robinson Proton pump inhibitors: update on their role in acid-related gastrointestinal diseases International Journal of Clinical Practice 59 6 2005 709 715 (Pubitemid 44192642)
50. T. Sasaki, M. Yamaya, and H. Yasuda The proton pump inhibitor lansoprazole inhibits rhinovirus infection in cultured human tracheal epithelial cells European Journal of Pharmacology 509 2-3 2005 201 210 (Pubitemid 40279079)
51. W. Schillinger, N. Teucher, and S. Sossalla Negative inotropy of the gastric proton pump inhibitor pantoprazole in myocardium from humans and rabbits: evaluation of mechanisms Circulation 116 1 2007 57 66 (Pubitemid 47016247)
52. S. Schulz-Geske, K. Erdmann, and W.o.n.g. Rj Molecular mechanism and functional consequences of lansoprazole-mediated heme oxygenase-1 induction World Journal of Gastroenterology 15 35 2009 4392 4401
53. Z.L. Shan, Y.T. Wang, and X.M. Shi Atrial mapping with unipolar electrode in goat model of persistent atrial fibrillation Chinese Journal of Cardiac Pacing and Electrophysiology 16 3 2002 212 215
54. Z.L. Shan, P.H. Van Der Voort, and Y. Blaauw Fractionation of electrograms and linking of activation during pharmacologic cardioversion of persistent atrial fibrillation in the goat Journal of Cardiovascular Electrophysiology 15 5 2004 572 580 (Pubitemid 38655951)
55. Z.L. Shan, J.F. Cheng, and Y.T. Wang Effects of Omeprazole on atrial electrical remodeling induced by rapid atrial pacing in rabbits Chinese Heart Journal 20 1 2008 34 36
56. H. Shimazu, G. Nakaji, and M. Fukata Relationship between atrial fibrillation and gastroesophageal reflux disease: a multicenter questionnaire survey Cardiology 119 2011 217 223
57. K. Shinagawa, K. Derakhchan, and S. Nattel Pharmacological prevention of atrial tachycardia induced atrial remodeling as a potential therapeutic strategy Pacing and Clinical Electrophysiology 26 3 2003 752 764 (Pubitemid 36399486)
58. W.B. Smith, J.R. Gamble, and I. Clark-lewis Interleukin-8 induces neutrophil transendithelial migration Immunology 72 1991 65 72
59. R. Stocker, and M.A. Perrella Heme oxygenase-1: a novel drug target for atherosclerotic diseases? Circulation 114 20 2006 2178 2189 (Pubitemid 44747899)
60. M. Suzuki, M. Nakamura, and M. Mori Lansoprazole inhibits oxygen-derived free radical production from neutrophils activated by Helicobacter pylori Journal of Clinical Gastroenterology 20 2 1995 S93 S96
61. M. Suzuki, M. Mori, and S. Miura Omeprazole attenuates oxygen-derived free radical production from human neutrophils Free Radical Biology and Medicine 21 5 1996 727 731 (Pubitemid 26331104)
62. D.R. Swanson Atrial fibrillation in athletes: implicit literature-based connections suggest that overtraining and subsequent inflammation may be a contributory mechanism Medical Hypotheses 66 6 2006 1085 1092
63. K. Toyama, H. Yamabe, and T. Uemura Analysis of oxidative stress expressed by urinary level of 8-hydroxy-2′-deoxyguanosine and biopyrrin in atrial fibrillation: effect of sinus rhythm restoration International Journal of Cardiology S0167-5273 12 2012 01174 01176 (pii)
64. J.H. Wandall Effects of omprazole on meutrophil chemotaxis, super oxide production, degranulation, and translocation of cytochrome b-245 Gut 33 5 1992 617 621
65. Y. Xu, D. Sharma, G. Li, and Y. Liu Atrial remodeling: new pathophysiological mechanism of atrial fibrillation ([Epub ahead of print]) Medical Hypotheses S0306-9877 12 2012 00460 00464 10.1016/j.mehy.2012.10.009 (pii)
66. M. Yeo, D.K. Kim, and I.S. Chung The novel acid pump antagonist for anti-secretory action with their peculiar applications beyond acid suppression Journal of Clinical Biochemistry and Nutrition 38 2006 1 8
67. N. Yoshida, T. Yoshikawa, and Y. Tanaka A new mechanism for anti-inflammatory actions of proton pump inhibitors-inhibitory effects on neutrophil-endothelial cell interactions Alimentary Pharmacology and Therapeutics 14 1 2000 74 81 (Pubitemid 30199109)
68. N. Yoshida, K. Uchiyama, and M. Kuroda Interleukin-8 expression in the esophageal mucosa of patients with gastroesophageal reflux disease Scandinavian Journal of Gastroenterology 39 9 2004 816 822 (Pubitemid 39215451)
69. K. Zedtwitz-Liebenstein, C. Wenisch, and S. Patruta Omeprazole treatment diminishes intra- and extracellular neutrophil reactive oxygen production and bacterical activity Critical Care Medicine 30 5 2002 1118 1122 (Pubitemid 34508037)